Pictet Asset Management Holding SA

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1993888 CAROUGE, V8

Position in REGN

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$95,713,390

-$164,862,540 QoQ

Shares Held

153,500

-54.5% QoQ

Ownership

0.149%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 79% Shared 0% None 21%

Healthcare · as of Jun 30, 2026

Pictet Asset Management Holding SA holds $3,959,193,705 across 131 Biotechnology names. REGN ranks #14 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	539,255	$267,864,136
2	RVMD	Revolution Medicines, Inc.	1,014,894	$190,069,348
3	ARGX	Argenx SE	198,282	$183,960,091
4	INSM	INSMED Inc	1,220,353	$130,114,036
5	IONS	Ionis Pharmaceuticals Inc	1,596,998	$126,625,971
6	ROIV	Roivant Sciences Ltd.	3,468,340	$122,744,552
7	BBIO	BridgeBio Pharma, Inc.	1,448,126	$107,856,424
8	RYTM	Rhythm Pharmaceuticals, Inc.	957,785	$106,342,868

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$95,713,390	153,500	-54.5%	Shares	Sole	2026-07-30
2026-03-31	$260,575,930	337,254	-8.3%	Shares	Sole	2026-04-22
2025-12-31	$283,947,816	367,870	+13.8%	Shares	Sole	2026-01-29
2025-09-30	$181,821,249	323,370	+6.3%	Shares	Sole	2025-11-18
2025-06-30	$159,666,675	304,127	+1.1%	Shares	Sole	2025-08-13
2025-03-31	$190,875,323	300,956	+40.6%	Shares	Sole	2025-05-05
2024-12-31	$152,507,716	214,097	-25.3%	Shares	Sole	2025-02-12
2024-09-30	$301,227,565	286,545	-2.5%	Shares	Sole	2024-11-12
2024-06-30	$308,754,776	293,764	-27.3%	Shares	Sole	2024-08-13
2024-03-31	$389,080,807	404,244	-6.9%	Shares	Sole	2024-05-14
2023-12-31	$381,529,176	434,400	+5.2%	Shares	Sole	2024-02-13
2023-09-30	$339,917,044	413,042	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.